[1] 中国心血管健康与疾病报告编写组, 胡盛寿, 王增武.《中国心血管健康与疾病报告2022》概要[J]. 中国介入心脏病学杂志, 2023, 31:485-508. [2] 王治财, 仓彦. 代谢组学在冠状动脉粥样硬化性心脏病中的研究进展[J]. 安徽医药, 2023, 27:1293-1297. [3] 刘泽鑫, 曹赛, 陈清, 等. MicroRNA-132通过诱导线粒体氧化应激障碍-铁死亡进程促进动脉粥样硬化[J]. 南方医科大学学报, 2022, 42:143-149. [4] Li K, Cui M, Zhang K, et al. M1 macrophages-derived extracellular vesicles elevate microRNA-185-3p to aggravate the development of atherosclerosis in ApoE-/- mice by inhibiting small mothers against decapentaplegic 7[J]. Int Immunopharmacol, 2021, 90:7138-7146. [5] Jiang Y, Xu CH, Zhao Y, et al. LINC00926 is involved in hypoxia-induced vascular endothelial cell dysfunction via miR-3194-5p regulating JAK1/STAT3 signaling pathway[J]. Eur J Histochem, 2023, 67:3526-3534. [6] 王丽萍, 徐敏, 缪羽霞, 等. 改良Gensini评分对2型糖尿病合并急性心肌梗死患者预后的预测价值[J]. 江苏医药, 2022, 48:1101-1105. [7] 王杨淦, 梁芳. 老年冠心病慢病管理指南[J]. 中西医结合研究, 2023, 15:30-42. [8] 高晓倩, 于华惠, 刘圣, 等. 血尿素氮水平对急性冠状动脉综合征患者PCI术后MACE的预测价值[J]. 基础医学与临床, 2024, 44:606-612. [9] HHo PTB, Clark IM, Le LTT. MicroRNA-based diagnosis and therapy[J]. Int J Mol Sci, 2022, 23:7167.doi:10.3390/ijms23137167. [10] 王凤林, 谢宝栋. microRNA在冠心病中的研究进展[J]. 心血管康复医学杂志, 2024, 33:252-255. [11] Wang Y, Bai Y, Liu Y, et al. Plasma exosomal miRNAs involved in endothelial injury in microscopic polyangiitis patients[J]. FASEB J, 2020, 34:6215-6228. [12] Dong Y, Li J, Cao D, et al. Integrated microRNA and secretome analysis of human endometrial organoids reveal the miR-3194-5p/Aquaporin/S100A9 module in regulating trophoblast functions[J]. Mol Cell Proteomics, 2023, 22:100526-100541. [13] 宋俊迎, 王琼, 李凤德. 老年人冠心病患病及冠状动脉病变严重程度的相关因素分析[J].中华老年心脑血管病杂志, 2023, 25:761-763. |